Our Proven Strategy
At Agent Capital, we have a balanced investment approach and a deep understanding of pipeline pressures in healthcare.
We participate in a wide range of financing rounds:
![](https://p3naee.p3cdn1.secureserver.net/wp-content/uploads/2021/12/Early-Stage-Financings.png?time=1721993954)
Early Stage Financings
(e.g., Seed investment, First Institutional Round)
![](https://p3naee.p3cdn1.secureserver.net/wp-content/uploads/2021/12/Later-Stage-Financings.png?time=1721993954)
Later Stage Financings
(e.g., Post-Series A, Crossover, PIPEs)
We have a primary focus on therapeutic areas with high, unmet medical need, including:
![](https://p3naee.p3cdn1.secureserver.net/wp-content/uploads/2018/07/svg-1.png?time=1721993954)
Rare Diseases
![](https://p3naee.p3cdn1.secureserver.net/wp-content/uploads/2018/07/svg-2.png?time=1721993954)
Oncology
![](https://p3naee.p3cdn1.secureserver.net/wp-content/uploads/2018/07/svg-3.png?time=1721993954)
Neurology
![](https://p3naee.p3cdn1.secureserver.net/wp-content/uploads/2018/07/svg-4.png?time=1721993954)
Immunology
×
We have a systematic approach to selecting and supporting each investment:
- Invest alongside other likeminded investors
- Lead or co-lead financing rounds
- Support experienced entrepreneurs and management teams
- Guide companies to milestones and exits
- Connect portfolio companies to our wide Pharma network of executives